CONFERENCES

    European Society for Alternatives to Animal Testing (3Rs Society)

    EUSAAT is an annual conference that explores public health research and policy in Europe, with topics ranging from health promotion to health systems. The conference is aimed at public health professionals, researchers, and policymakers involved in the study and promotion of public health in Europe, and provides a forum for sharing knowledge and collaborating on new approaches to improving public health outcomes.

    23rd EUSAAT Congress 2022

    Date

    Sep 26, 2022 - Sep 28, 2022

    Location

    Linz, Austria

    This year's Congress includes discussions on new concepts of implementing the 3Rs in academic education at the European and international level.

    See related posters

    18th EUSAAT Congress 2018

    Date

    Sep 23, 2018 - Sep 26, 2018

    Location

    Linz, Austria

    Bringing together 300 participants, this Congress has for theme “International Progress in 3Rs Research” and provides a comprehensive communication platform covering all different aspects and groups from the 3Rs field.

    13th EUSAAT Congress 2013

    Date

    Sep 15, 2013 - Sep 18, 2013

    At the Congress, PMI scientists present the research on biological network models which results from a scientific collaboration between PMI and IBM’s Thomas J. Watson Research Center. 

    See related posters

    See related presentations

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.